(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-31 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1314051
Date | Daily Closing Price | Open | High | Low | Volume |
31 Fri May 2024 | 1.13 | 1.15 | 1.18 | 1.04 | 11.357 times |
30 Thu May 2024 | 1.01 | 1.05 | 1.07 | 1.00 | 2.986 times |
29 Wed May 2024 | 1.01 | 1.03 | 1.04 | 1.00 | 0.63 times |
28 Tue May 2024 | 1.04 | 1.08 | 1.10 | 1.02 | 0.829 times |
23 Thu May 2024 | 1.01 | 1.05 | 1.06 | 1.01 | 0.609 times |
22 Wed May 2024 | 1.05 | 1.08 | 1.12 | 1.05 | 0.559 times |
21 Tue May 2024 | 1.08 | 1.09 | 1.11 | 1.06 | 1 times |
20 Mon May 2024 | 1.10 | 1.12 | 1.12 | 1.05 | 0.529 times |
17 Fri May 2024 | 1.11 | 1.16 | 1.17 | 1.10 | 0.799 times |
16 Thu May 2024 | 1.20 | 1.34 | 1.34 | 1.15 | 0.979 times |
Stock of Adaptimmune Therapeutics (ADAP) has showed a significant upmove. This could be a good time to enter in this stock!
My analysis of stock is bullish for shortterm, and stock might move up till 1.2 or till 1.3. Use a stoploss of 1.12 and if this stock hits its stoploss, then it can fall down till 1.05
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.65 |
Downside Target | 0.87 |
Downside Target | 0.92 |
Downside Target | 1.00 |
Downside Target | 1.07 |
Downside Target | 1.10 |
Upside Target | 1.18 |
Upside Target | 1.23 |
Upside Target | 1.25 |
Upside Target | 1.34 |
Upside Target | 1.55 |
Upside Target | 1.79 |
Upside Target | 2.05 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 1.03 |
Downside Intraday Target | 0.92 |
Upside Intraday Target | 1.21 |
Upside Intraday Target | 1.28 |
Downside Intraday Target | 1.1 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
31 Fri May 2024 | 1.13 | 1.08 | 1.18 | 1.00 | 5.858 times |
23 Thu May 2024 | 1.01 | 1.12 | 1.12 | 1.01 | 0.751 times |
17 Fri May 2024 | 1.11 | 1.12 | 1.34 | 1.10 | 1.078 times |
10 Fri May 2024 | 1.12 | 1.23 | 1.23 | 1.02 | 1.022 times |
03 Fri May 2024 | 1.19 | 1.09 | 1.25 | 1.07 | 0.987 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
31 Fri May 2024 | 1.13 | 1.19 | 1.34 | 1.00 | 1.279 times |
30 Tue Apr 2024 | 1.19 | 1.55 | 1.55 | 0.87 | 0.71 times |
28 Thu Mar 2024 | 1.58 | 1.56 | 2.05 | 1.24 | 1.055 times |
29 Thu Feb 2024 | 1.57 | 1.03 | 1.79 | 0.92 | 0.965 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.1 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.1 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.